Treatment-naive adults were randomized to nevirapine ( NVP ) or ritonavir-boosted lopinavir ( LPV/r ) regimens each in combination with tenofovir ( TDF ) / emtricitabine ( FTC ) or zidovudine ( ZDV ) / lamivudine ( 3TC ) .